Case-Control Studies

Abo-Tabik, M., Parisi, R., Morgan, C., Willis, S., Griffiths, C. E., & Ashcroft, D. M. (2022). Mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK: results from two matched case-control studies. Br J Gen Pract, 72, e834-e841. http://doi.org/10.3399/bjgp.2022.0137
Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2022). Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout. Jama, 328, 440-450. http://doi.org/10.1001/jama.2022.11390
Rafiq, M., Abel, G., Renzi, C., & Lyratzopoulos, G. (2022). Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years. Br J Gen Pract, 72, e546-e555. http://doi.org/10.3399/bjgp.2021.0617
Abenhaim, H. A., Suissa, S., Azoulay, L., Spence, A. R., Czuzoj-Shulman, N., & Tulandi, T. (2022). Menopausal Hormone Therapy Formulation and Breast Cancer Risk. Obstet Gynecol, 139, 1103-1110. http://doi.org/10.1097/aog.0000000000004723
Amegadzie, J. E., Gamble, J. M., Farrell, J., & Gao, Z. (2022). Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study. Int J Chron Obstruct Pulmon Dis, 17, 1205-1217. http://doi.org/10.2147/copd.s358927